Об авторах
Озерова Ирина НиколаевнаФГБУ «Государственный научно-исследовательский центр профилактической медицины» Минздрава России 101990, г. Москва, Российская Федерация канд. биол. наук, вед. научн. сотр. viozerova@gnicpm.ru
Список литературы
Carmena R., Duriez P., Fruchart J.C. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109(23 Suppl.1): III2-7.
Toft-Petersen A.P., Tilsted H.H., Aarøe J., Rasmussen K., Christensen T., Griffin B.A. et al. Small dense LDL particles — a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study. Lipids Health Dis. 2011; 10: 21-7.
Berneis K.K., Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid. Res. 2002; 43(9): 1363-79.
Navab M., Reddy S.T., Van Lenten B.J., Fogelman A.M. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat. Rev. Cardiol. 2011; 8(4): 222-32.
Pirillo A., Norata G.D., Catapano A.L. High-density lipoprotein subfractions — what the clinicians need to know. Cardiology. 2013; 124(2): 116-252.
Kosmas C.E., Christodoulidis G., Cheng J.W., Vittorio T.J., Lerakis S. High-density lipoprotein functionality in coronary artery disease. Am. J. Med. Sci. 2014; 347(6): 504-8.
Hoefner D.M., Hodel S.D., O’Brien J.F., Branum E.L., Sun D., Meissner I. et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin. Chem. 2001; 47(2): 266-74.